|
C2ORF86 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.369400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.407210E-01 |
| Normal-vs-Stage2 |
8.353000E-01 |
| Normal-vs-Stage3 |
2.442400E-01 |
| Normal-vs-Stage4 |
7.458300E-02 |
| Stage1-vs-Stage2 |
5.404000E-01 |
| Stage1-vs-Stage3 |
9.807600E-01 |
| Stage1-vs-Stage4 |
6.128200E-01 |
| Stage2-vs-Stage3 |
5.230800E-01 |
| Stage2-vs-Stage4 |
3.047400E-01 |
| Stage3-vs-Stage4 |
4.979400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.968600E-01 |
| Normal-vs-AfricanAmerican |
3.880000E-01 |
| Normal-vs-Asian |
1.197780E-01 |
| Caucasian-vs-AfricanAmerican |
8.206000E-01 |
| Caucasian-vs-Asian |
5.016400E-01 |
| AfricanAmerican-vs-Asian |
5.346000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.318200E-02 |
| Normal-vs-Female |
3.245200E-01 |
| Male-vs-Female |
1.633520E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.141450E-01 |
| Normal-vs-Extreme_Weight |
8.197900E-03 |
| Normal-vs-Obese |
7.827600E-01 |
| Normal-vs-Extreme_Obese |
9.170800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.233200E-01 |
| Normal_Weight-vs-Obese |
2.618400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.783800E-01 |
| Extreme_Weight-vs-Obese |
3.635700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.611000E-01 |
| Obese-vs-Extreme_Obese |
9.845200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.566000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.214400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.971450E-01 |
| Normal-vs-Age(81-100Yrs) |
1.227000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.431200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.476800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.712600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.560000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.177600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.592400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.289000E-01 |
| Normal-VS-Type2 PRCC |
3.110200E-01 |
| Normal-VS-KIRP CIMP |
4.311200E-01 |
| Normal-VS-Unclassified PRCC |
6.658400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.821600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.929000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.952000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.391400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.080600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.198600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.034400E-02 |
| Normal-vs-N1 |
5.683000E-01 |
| Normal-vs-N2 |
2.021000E-01 |
| N0-vs-N1 |
4.664200E-01 |
| N0-vs-N2 |
9.022400E-01 |
| N1-vs-N2 |
6.439200E-01 |
|
|
